Atlas Trials

A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia.

Clinical trial NCT03528681 · COMPLETED

Trial details

NCT number
NCT03528681
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hyperkalemia
Start date
2021-05-06
Primary completion
2022-09-15
Enrollment
270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.